Minireviews
Copyright ©The Author(s) 2023.
World J Gastroenterol. Jan 28, 2023; 29(4): 656-669
Published online Jan 28, 2023. doi: 10.3748/wjg.v29.i4.656
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Effects of COVID-19 and liver injury interaction. COVID-19: Coronavirus disease 2019; DILI: Drug induced liver injury.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Course of liver cirrhosis during COVID-19. UGI: Upper gastrointestinal; HRS: Hepatorenal syndrome; HE: Hepatic encephalopathy.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Complex interplay of non-alcoholic fatty liver disease and COVID-19. COVID-19: Coronavirus disease 2019; NAFLD: Non-alcoholic fatty liver disease; ARDS: Acute respiratory distress syndrome; ROS: Reactive oxygen species; IL-6: Interleukin-6.